Learn how Indica Labs’ customers employ HALO products for life science, clinical, and diagnostic use cases.
Indica Labs is pleased to announce our London HALO® User Group Meeting at Hilton London Metropole on December 10 from 12:00 – 16:00. A lunch will be provided to all pre-registered attendees and a drinks reception will follow the event from 16:00 – 17:00.
Our program this year features three distinguished guest speakers who will discuss how they use AI-based phenotypers in HALO AI to advance breast cancer research, how HALO AP® is being deployed at Med Uni Graz for primary diagnostics, and how Breast IHC AI is advancing diagnostics at the University Hospital Bern. In addition to our guest speakers, Indica Labs will present an introduction and live demonstration of our image analysis and image management platforms for life sciences, introduce our offering in clinical AI and Cloud Services, and reflect on milestones and innovations enabled by HALO AP®.
We welcome anyone who is interested in learning more about Indica Labs’ quantitative digital pathology solutions to register for the meeting. You do not need to be a current Indica Labs customer to attend. Apply for a place here.
Agenda
Welcome Address (12:00 – 12:10)
Dr. Kate Lillard, Chief Scientific Officer, Indica Labs
HALO and HALO AI: AI-Powered Image Analysis (12:10 – 12:45)
Pedro Espinosa Gonzalez, Field Applications Scientist, Indica Labs
Join us for a live demonstration of the intuitive HALO image analysis platform and HALO AI deep learning toolset. This session will highlight HALO’s powerful analytic capabilities as well as its flexibility and scalability supporting diverse areas of research. Topics include the pretrained AI-based nuclear and membrane segmentation networks available in HALO 4.0, which play a game-changing role compared to traditional tools. We will also introduce the latest networks released this year for HALO AI. These pretrained AI-based networks can be re-trained by the user to better fulfil the specific needs of a project and the trainable AI tissue classifiers can be used to segment the different compartments of each tissue. Learn how to train the different networks using the new Training Sessions feature and how to utilize the new Classifier Pipeline feature to accomplish routine detection workflows with efficiently trained classifiers having a limited number of classes.
HALO Link: Promoting Discovery Through Collaboration (12:45 – 1:00)
Pedro Espinosa Gonzalez, Field Applications Scientist, Indica Labs
In this presentation we will focus on HALO Link, our image management platform for the life sciences, which facilitates collaboration, study management, image and metadata integration, and visualization of data. We will cover common workflows in HALO Link, and will discuss how different users, with various permission levels, can access images and will demonstrate tasks that can be accomplished using the browser-based platform. Discover the powerful plotting functionalities available to visualize data across a study, including heatmaps, scatter plots, violin plots, and box and whisker plots. Additionally, learn about the new tools in version 4.0 supporting auditing and Good Laboratory Practices (GLP).
Coffee Break (1:00 – 1:20)
Digital Analysis of Metastatic Breast Cancer Using Cellular Phenotyping and Spatial Transcriptomics (1:20 – 1:50)
Dr. Katherine Sheehan, Consultant Pathologist, Pathology Laboratory, Blackrock Health, Dublin;
Senior Lecturer & Consultant Pathologist, Depts of Pathology & Surgery, Royal College of Surgeons in Ireland
In this presentation, we will show the use of HALO software in the differentiation of metastatic breast carcinoma from surrounding neural tissue types in the brain. Our study uses several components of the HALO AI platform, including tissue classification, object phenotyping and spatial analysis modules. In addition, the cellular localization and subclassification on routine H&E sections will be compared with spatial transcriptomics data that have been deployed on the same tissues.
HALO AP Five Years On: Milestones, Innovations, and the Future of AP Labs (1:50 – 2:10)
Katie McKinley, VP, Clinical Applications, Indica Labs
Since its launch in late 2019, HALO AP® has transformed AP labs of varying scales and specializations. In this session, we will reflect on the key drivers behind our development over the past five years, highlighting our first-in-market tools that have set industry standards and enhanced client workflows. We will also explore what’s next for HALO AP®, discussing the evolving needs of the industry and how we plan to continue leading the way in innovation and efficiency.
HALO Clinical AI Solutions: From Research and Development to the Clinic (2:10 – 2:25)
Dr. Peter Caie, Sr. Principal Scientist, AI Diagnostics, Indica Labs
This session will introduce Indica Labs’ current HALO Clinical AI solutions. We will describe how the AI Diagnostics team utilizes Indica Labs software to collaborate with external industrial, clinical, and academic partners during the research, development, validation, and deployment of our clinical AI products.
Coffee break (2:25 – 2:45)
Implementing Digital Pathology: The Step from Research to Diagnostics (2:45 – 3:15)
Markus Plass, Researcher, Technical Lead Digital Pathology and Computational Pathology
Medical University of Graz
The Institute of Pathology at the Medical University of Graz is currently in the process of transitioning its diagnostics to digital pathology. Over the past few years, approximately half a million slides from the biobank have been digitized. This presentation will focus on how digitization can be transferred from research and teaching into routine diagnostics and how these areas can benefit from each other.
Optimizing Digital Pathology Infrastructure Through Cloud Services (3:15 – 3:25)
Billy Heseltine, Director of Cloud Services, Indica Labs
This presentation will delve into how the Indica Labs Cloud Services team can elevate your HALO infrastructure through customized cloud solutions. Our expert engineers, proficient in both cloud technology and digital pathology, provide optimized deployments and exceptional support. Discover how our tailored approach ensures robust, scalable, and efficient operations for your digital pathology needs.
Deploying Indica Labs Software at the University of Bern and Its Use for Clinical Reporting and Research Projects (3:25 – 3:55)
Dr. Wiebke Solass, Head of Gynecological Pathology, University Hospital Bern
At the University of Bern, the slogan “Tissue Medicine is the New Pathology” describes our vision of conducting holistic digital pathology-driven patient-oriented diagnostics and research. In this talk, I will briefly discuss our current reporting of breast cancer immunohistochemistry, the plans at Bern to integrate and deploy both HALO AP and Breast IHC AI into our clinical workflow, and the predicted efficiency gains we aim to achieve by doing so. I will also describe how Indica Labs’ clinical software can be utilized to undertake research projects and train medical students at the University of Bern; focusing on a recent study comparing undergraduate breast cancer IHC scoring to that of trained pathologists, when assisted by Breast IHC AI.
Closing Remarks (3:55 – 4:00)
Dr. Kate Lillard, Chief Scientific Officer, Indica Labs
Drinks Reception (4:00 – 5:00)
